SCIENCE / EVIDENCE BASE
Ambrosine joins a serviceable port to a confined, responsive hydrogel so a bounded command can become a measurable local output.
Published work validates the ingredients separately. No study has validated the integrated Ambrosine architecture.
FOUNDATIONAL THESIS
Hydrogels can carry charge, change permeability, hold payloads, and conform to living tissue. Ports can preserve repeatable clinical access. The opportunity is to engineer them as one characterized interface—not simply place them beside each other.
PUBLISHED MILESTONES
Independent work from other teams. These are precedents, not Ambrosine results.
Electrical command released GABA across 50 bench cycles; one triggered release exceeded passive release by at least 1,000× in the same time window, with output declining as preload depleted.
A cortical microneedle array in an induced seizure model—not a refillable neural port.Qu et al., Science Advances ↗An injectable conductive hydrogel held approximately 120 Ω impedance at 1 kHz after four weeks in 37°C buffer and supported chronic rat-vagus stimulation.
A peripheral electrical interface—not chemical release, CSF delivery, or a human implant.Yang et al., Nature Communications ↗Self-sealing ports enabled repeat refills. In four primates, month-four refill produced an overall mean plasma tenofovir concentration not significantly different from immediate refill, although days 14 and 28 differed.
A subcutaneous nanofluidic reservoir—not hydrogel, neural placement, or local CNS delivery.Di Trani et al., Advanced Therapeutics ↗Five adults received ventricular-CSF valproate for a mean 12.5 months with the final pump; at the highest tested dose, four reached greater than 50% seizure reduction.
A small uncontrolled study; initial pump failure required reimplantation in all five participants, with possible valproate–component interactions cited.Cook et al., EClinicalMedicine ↗AMBROSINE VALIDATION PROGRAM
Planned work—not current results.
Measure gelation, swelling, degradation, conductivity, extractables, cytotoxicity, and sterilization stability in artificial CSF.
Use a nonactive tracer to quantify passive leak, trigger latency, delivered mass, repeatability, drift, and fail-closed behavior.
Cycle access, aspiration, refill, purge, and resealing in a tissue phantom while measuring leakage, backflow, occlusion, and septum wear.
Combine one payload class, one trigger, one port, and one dock; then compare logged commands with assayed local output across manufacturing lots.
A sealed port–gel circuit that releases a blinded tracer dose on command, stays contained while off, and returns to the same release profile after refill. For an implantable-device or CNS-therapeutic team, it turns uncertainty into a go, redesign, or stop integration decision.